CN Stock MarketDetailed Quotes

688513 Chengdu Easton Biopharmaceuticals

Watchlist
  • 36.75
  • +0.07+0.19%
Trading Nov 13 09:44 CST
6.49BMarket Cap25.95P/E (TTM)

Chengdu Easton Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Preparation sales564.91M84.38%
Bulk drug sales57.36M8.57%
CMO/CDMO26.57M3.97%
技术服务及转让19.97M2.98%
Other711.38K0.11%
Industry Currency:CNY
2023/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry1.12B99.87%
Other business1.42M0.13%
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
East China region252.82M37.76%
Southwest area127.76M19.08%
North China95.26M14.23%
South China83.98M12.54%
Central China49.59M7.41%
Northeast area32.18M4.81%
Northwest region17.87M2.67%
Overseas region10.05M1.50%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data